SCHEMBL311535

SCHEMBL311535

CCOC(=O)Nc1nc(O)ccc1-c1cc(=O)c2cccc(O)c2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.44
KDM4E B2RXH2 6/20 0.44
HSD17B10 Q99714 4/20 0.44
LMNA P02545 1/20 0.44
CYP3A4 P08684 5/20 0.41
CYP2C19 P33261 4/20 0.41
TSHR P16473 1/20 0.41
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
ALDH1A1 P00352 3/20 0.39
LOXL2 Q9Y4K0 1/20 0.38
GLA P06280 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 4/20 0.38
MEN1 O00255 3/20 0.38
CYP2C9 P11712 3/20 0.38
RECQL P46063 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP2D6 P10635 2/20 0.38
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312401 0.86 KDM4E (0.59) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311987 0.85 ATM (0.50) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311431 0.82 HPGD (0.46) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311723 0.82 HPGD (0.43) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL312214 0.81 HPGD (0.47) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311355 0.81 AKR1B1 (0.51) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL312402 0.76 HPGD (0.43) HPGDKDM4EHSD17B10LMNACYP2C19
SCHEMBL312366 0.73 KDM4E (0.58) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311828 0.73 CYP2D6 (0.46) HPGDKDM4EHSD17B10LMNACYP3A4
SCHEMBL311794 0.73 CYP3A4 (0.44) HPGDKDM4EHSD17B10CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed